Capillary Technologies Releases Q2 FY27 Earnings Call Transcript
Capillary Technologies released its Q2 FY27 earnings call transcript. The company reported Q2 revenue growth of 51% YoY to ₹271 crore and adjusted EBITDA of ₹44.8 crore (17% margin). Organic NRR was 116%, and new customer wins increased by 79% YoY. The aiRA platform's expanded capabilities and acquisition integration were key discussion points.
The transcript provides a detailed overview of the company's financial health, strategic initiatives, product development (AI, Experience Plus), and acquisition integration, which are material for investors and stakeholders.
The announcement is positive as it details strong financial performance with significant year-on-year growth in revenue and EBITDA, coupled with positive commentary on customer acquisition and product development.
Capillary Technologies India Limited has announced the release of the transcript for their earnings conference call held on November 02, 2026. The call focused on the financial results for the quarter and half-year ended September 30, 2026.
During the call, the management highlighted the company's performance across several growth levers, including Net Retention Rate (NRR), new customer acquisition, and inorganic growth through Mergers & Acquisitions (M&A). The organic NRR was reported at 116% for Q2, with growth driven by increased platform usage, product upgrades, and expansion into new markets. New customer acquisition saw a significant year-on-year increase of approximately 79% on a constant currency basis, largely attributed to the company's AI stack.
The company also discussed its profitability levers, emphasizing NRR-linked margin expansion and operating leverage on non-cost of goods sold (COGS) expenses. Gross margins remained stable at 67%, even with the inclusion of Session M, an acquired entity. The management detailed the revenue and adjusted EBITDA performance for Q2 and H1 FY27, showing substantial year-on-year growth. Adjusted EBITDA for Q2 stood at ₹44.8 crore, reflecting a 17% margin, while H1 adjusted EBITDA was ₹89 crore, also at 17% margin.
Discussions also touched upon the company's AI platform, aiRA, and its expanded capabilities, including integration with acquisition channels like Google Ads and Meta. The company is also seeing traction with its 'Experience Plus' product, rebranded from Customer Glue IP. The transcript further elaborated on the integration of acquired companies, the migration process of their customers, and efforts to optimize server costs, particularly for Session M.
The company ended the quarter with a cash balance of ₹573 crore and reported zero long-term debt. Operating cash flow to adjusted EBITDA stood at 128%, indicating strong cash generation. The call also included a Q&A session where analysts inquired about aiRA's capabilities, deal sizes, the impact of AI agents on loyalty programs, and the migration strategy for acquired customers.
What to do with a filing like this
Capillary Technologies India Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Capillary Technologies India Limited. Read the original for the full detail.